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Abstract
Purpose The use of an intraoperative tourniquet for total
knee arthroplasty (TKA) is a common practice. However,
the effectiveness and safety are still questionable. A sys-
tematic review was conducted to examine that whether
using a tourniquet in TKA was effective without increasing
the risk of complications.
Methods A comprehensive literature search was done in
PubMed Medicine, Embase, and other internet database.
The review work and the following meta-analysis were
processed to evaluate the role of tourniquet in TKA.
Results Eight randomized controlled trials and three
high-quality prospective studies involving 634 knees and
comparing TKA with and without the use of a tourniquet
were included in this analysis. The results demonstrated
that using a tourniquet could decrease the measured blood
loss but could not decrease the calculated blood loss, which
indicated actual blood loss. Patients managed with a tour-
niquet might have higher risks of thromboembolic com-
plications. Using the tourniquet with late release after
wound closure could shorten the operation time; whereas
early release did not show this beneﬁt.
Conclusions The current evidence suggested that using
tourniquet in TKA may save time but may not reduce the
blood loss. Due to the higher risks of thromboembolic
complications, we should use a tourniquet in TKA with
caution.
Keywords Tourniquet  Knee arthroplasty  Blood loss 
Thromboembolism  Meta-analysis
Introduction
Total knee arthroplasty (TKA) is associated with signiﬁ-
cant blood loss, for which blood transfusion might be
necessary. The role of the tourniquet is controversial,
though it is widely used by orthopedic surgeons. Its use
was believed to be effective in decreasing intraoperative
blood loss and creating a bloodless surgical ﬁeld, which
theoretically would facilitate the cementing technique and
other surgical procedures. However, reactive blood ﬂow
reached its peak within 5 min after the tourniquet had been
released [16]. The tourniquet controls intraoperative blood
loss, but cannot stop postoperative blood loss. The role of
the tourniquet in the total blood loss of patients undergoing
TKA is still questionable.
In addition, the beneﬁts of the tourniquet must be bal-
anced against the shortages and risks. Patients who were
managed with a tourniquet during the operation often
complained of thigh pain. This was possibly caused by the
direct pressure of an inﬂated tourniquet on the nerves and
local soft tissues. Limb swelling and increased soft tissue
tension caused by reactive hyperperfusion after tourniquet
deﬂation may also contribute to the wound pain.
Thromboembolism is one of the most serious postop-
erative complications in orthopedic surgery. Clinically, the
use of the pneumatic tourniquet is considered to be one of
the most important risk factors for symptomatic thrombo-
embolism [13, 37]. The incidence of deep vein thrombosis
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DOI 10.1007/s00167-010-1342-7(DVT) after TKA performed with a tourniquet was repor-
ted to be up to 72–84% in earlier studies [20, 31], but this
has been reduced with the advances in thromboembolic
prophylaxis. The deﬂation of a tourniquet also changes the
hemodynamic status [26] and allows a substantial amount
of emboli to travel from the lower limb into the right
atrium, right ventricle, and pulmonary artery [3]. This
phenomenon may be predictive of further clinical pul-
monary embolic events.
Other tourniquet-related complications have been
reported in the literature and include nerve palsy [10],
vascular injuries [15], rhabdomyolysis [24], and subcuta-
neous thigh fat necrosis [32]. The application of a tour-
niquet also tethers the quadriceps mechanism and thus
alters the intraoperative patellofemoral tracking [11, 14,
19]. This change may affect the surgeon’s judgment on
soft tissue balancing and the decision to perform lateral
release.
Several randomized controlled trials regarding the use of
tourniquets have been published, but no consensus has
been reached. Heterogeneous data had been reported in
these trials. Thus, a meta-analysis was conducted to assess
the effects of using a tourniquet for primary TKA, with the
aim of quantifying the effect of the tourniquet on reducing
blood loss and assessing the possible risks associated with
tourniquets.
Methods
We followed the methodological guidelines outlined by the
Cochrane Collaboration (Oxford, United Kingdom) [9]i n
conducting this meta-analysis. The ﬁndings were reported
according to the recommendations outlined in the Quality
of Reporting of Meta-Analyses (QUOROM) statement
[21].
Literature search
Two of the authors completed a search of the electronic
databases, including the Cochrane Central Register of
Controlled Trials (2009), PubMed Medline (1966–2009),
and Embase (1980–2009). We used the following search
terms and Boolean operators: ‘‘tourniquet’’ AND (‘‘knee
arthroplasty’’ OR ‘‘knee replacement’’). Editorials and
commentaries from major orthopedic journals were also
considered for further information on trials of interest. We
also used the internet search engine ‘‘Google’’, searching
under the keyword ‘‘tourniquet’’ combined with ‘‘knee,’’
‘‘arthroplasty,’’ ‘‘joint replacement,’’ ‘‘blood loss,’’ ‘‘deep
vein thrombosis,’’ or ‘‘pulmonary embolism.’’ The refer-
ence lists of the relevant articles were also looked through
for any further relevant studies.
Article selection and validity assessment
We included prospective trials comparing patients under-
going TKA with a tourniquet or not. Retrospective studies
or case series were excluded. The blood loss and incidence
of thromboembolic events were considered as primary
outcomes. After reviewing the titles and abstracts of the
studies, we determined whether the study was appropriate
for retrieval. We then appraised the studies and identiﬁed
those eligible for inclusion in our analysis. Using the
Consolidated Standards of Reporting Trials (CONSORT)
checklist of 22 items [22], we assessed the quality of
reporting in each article. All disagreements were resolved
by consensus.
Data extraction
Two authors independently extracted the data from the
articles. Whenever necessary, we contacted the authors of
the studies for the missing data or further information.
Encountering any disagreement, we reached a consensus
by discussion within the review team. The following data
were extracted: (1) participant demographics; (2) indica-
tion for TKA; (3) operative methods and usage of the
tourniquet; (4) blood loss measures, including the intra-
operative blood loss, amount of drainage, total measured
blood loss, and calculated blood loss; (5) operation time;
(6) thromboembolic events and other tourniquet-related
complications. We also contacted the authors for missing
data.
Statistical analysis
The outcomes were collected using variance-weighted
means. We tested for the presence of heterogeneity with
the use of a standard chi-square test (with a level of sig-
niﬁcance of P = 0.1) and the I
2 statistic [8]. An I
2 statistic
value of [50% was considered to indicate substantial
heterogeneity. Random-effects analysis [4] was used for
comparing trials showing heterogeneity while ﬁxed-effects
analysis [17] was used for comparing trials without
showing heterogeneity. We calculated the mean difference
or relative risk for all outcomes. The meta-analysis was
carried out using the RevMan 5 software package (Coch-
rane Collaboration, Oxford, United Kingdom).
Results
Identiﬁed trials
A total of 810 articles were retrieved in the search. Eight
randomized controlled trials and three high-quality
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123prospective studies (evidence-based level II) comparing
TKA with and without the use of a tourniquet were iden-
tiﬁed and included in the meta-analysis (Table 1). These
studies involved a total of 634 TKAs. The characteristics of
operation methods were summarized in Table 2. They
included some co-factors that might inﬂuence the blood
loss in TKA.
Methodology
The methodological quality of the included studies is
summarized in Table 1. The inclusion criteria were
reported in all studies, but the exclusion criteria were
made known in only four studies. No study reported the
method of random sequence generation and the detailed
implementation of randomization. Baseline characteristics
were not reported in one study [37], which could poten-
tially bias the results and limit the generalizability of the
ﬁndings.
Outcome analysis
Intraoperative blood loss and postoperative blood drainage
were reported in ﬁve studies. The pooling data showed that
using a tourniquet signiﬁcantly decreased the blood loss
during the operation but slightly increased the postopera-
tive blood loss (Fig. 1c, d). In terms of total measured
blood loss (the sum of intraoperative and postoperative
blood loss), the pooling data of the ﬁve studies favored
using a tourniquet (Fig. 1a). However, after taking out an
extreme data [7], the pooling result of the remaining
studies showed no signiﬁcant difference between these two
groups.
Three studies mentioned calculated blood loss, which
involved taking the patients’ blood volume and change in
hematocrit levels into consideration, and was thought to be
an exact representation of the true blood loss. The pooling
results surprisingly revealed slightly less calculated blood
loss in the non-tourniquet group (Fig. 1b).
With respect to thromboembolic events after surgery,
eight studies provided data on the incidence of sonographic
or clinical DVT and pulmonary embolism. The pooling
results found that the risk of clinical thromboembolic
events was signiﬁcantly higher in the tourniquet group than
in the non-tourniquet group (Fig. 2a). Symptomatic
thromboembolic events occurred in 13.0 and 6.1% of
patients in the tourniquet and non-tourniquet group,
respectively (Table 3). In the subgroup analysis, both
symptomatic DVT and pulmonary embolism occurred
more often in the tourniquet group than in the non-tour-
niquet group, although there was no statistical difference
(Fig. 2b, c). One study [36] claimed there were no DVTs in
either group. Two studies investigated the incidence of
DVT using sonographic image examinations [5, 36]. The
diversity of results indicated that the sonographic exami-
nation was operator dependent. The pooled results showed
no difference between the tourniquet and non-tourniquet
groups (Fig. 2d).
Transesophageal echocardiography was used to detect
intraoperative emboli in two studies [12, 37], and both of
them reported that snowstorm-like echogenic particles
were observed after deﬂation of the tourniquet in all
Table 1 Characteristics of the studies
No. in
tourniquet
group
No. in
non-tourniquet
group
Mean age
(tourniquet/
non-tourniquet)
Type of cohort CONSORT
methodology
score
Abdel-Salam [1] 40 40 67.2/65.4 Randomized controlled trial 9
Harvey [7] 36 28 63.2/61.4 Part of a prospective double-blinded
study on thromboprophylaxis
NA
Wakankar [36] 37 40 72.5/71.8 Randomized controlled trial 9
Aglietti [2] 10 10 70/68 Randomized controlled trial 12
Tetro [33] 33 30 69.8/69.8 Randomized controlled trial 15
Kato [12] 22 24 63/65 Randomized controlled trial 9
Vandenbussche [35] 40 40 80.3/72.5 Randomized controlled trial 11
Wauke [37] 19 18 68/69 Randomized controlled trial 9
Nishiguchi [23] 14 25 71.2/73.1 High-quality prospective study NA
Fukuda [5] 27 21 72/74 High-quality prospective study NA
Li [18] 40 40 71/70 Randomized controlled trial 11
Total 318 316 – – –
NA not applicable
Knee Surg Sports Traumatol Arthrosc (2011) 19:1121–1130 1123
123T
a
b
l
e
2
C
h
a
r
a
c
t
e
r
i
s
t
i
c
s
o
f
o
p
e
r
a
t
i
o
n
m
e
t
h
o
d
s
T
o
t
a
l
o
p
e
r
a
t
i
o
n
t
i
m
e
(
m
i
n
u
t
e
)
a
T
i
m
i
n
g
o
f
t
o
u
r
n
i
q
u
e
t
r
e
l
e
a
s
e
b
N
u
m
b
e
r
o
f
d
r
a
i
n
s
T
i
m
i
n
g
o
f
r
e
m
o
v
i
n
g
t
h
e
d
r
a
i
n
c
P
o
s
t
o
p
e
r
a
t
i
v
e
d
r
e
s
s
i
n
g
T
o
u
r
n
i
q
u
e
t
g
r
o
u
p
N
o
n
-
t
o
u
r
n
i
q
u
e
t
g
r
o
u
p
A
b
d
e
l
-
S
a
l
a
m
[
1
]
6
0
–
1
0
5
6
0
–
9
5
L
a
t
e
2
N
A
W
o
o
l
a
n
d
c
r
e
p
e
b
a
n
d
a
g
e
H
a
r
v
e
y
[
7
]
1
5
0
1
3
3
L
a
t
e
1
P
o
s
t
o
p
e
r
a
t
i
v
e
4
8
h
o
r
w
h
e
n
t
h
e
p
e
r
s
h
i
f
t
d
r
a
i
n
a
g
e
\
2
5
m
l
B
a
n
d
a
g
e
W
a
k
a
n
k
a
r
[
3
6
]
N
A
N
A
N
A
1
4
8
N
A
A
g
l
i
e
t
t
i
[
2
]
9
0
±
1
8
9
6
±
1
1
E
a
r
l
y
r
e
l
e
a
s
e
d
f
o
r
h
e
m
o
s
t
a
s
i
s
a
f
t
e
r
t
h
e
c
o
m
p
o
n
e
n
t
s
w
e
r
e
c
e
m
e
n
t
e
d
i
n
p
l
a
c
e
2
2
4
N
A
T
e
t
r
o
[
3
3
]
8
3
±
1
3
8
1
±
1
3
E
a
r
l
y
r
e
l
e
a
s
e
d
f
o
r
h
e
m
o
s
t
a
s
i
s
a
f
t
e
r
t
h
e
b
o
n
e
c
e
m
e
n
t
h
a
d
s
e
t
1
3
6
J
o
n
e
s
t
y
p
e
o
f
s
o
f
t
c
o
m
p
r
e
s
s
i
o
n
b
a
n
d
a
g
e
K
a
t
o
[
1
2
]
1
1
1
±
4
1
1
1
1
±
1
3
L
a
t
e
N
A
N
A
N
A
V
a
n
d
e
n
b
u
s
s
c
h
e
[
3
5
]
1
5
1
1
5
6
.
5
L
a
t
e
2
W
h
e
n
d
r
a
i
n
a
g
e
\
1
0
0
m
l
/
1
2
h
C
o
m
p
r
e
s
s
i
v
e
d
r
e
s
s
i
n
g
p
l
u
s
w
o
o
l
a
n
d
c
r
e
p
e
b
a
n
d
a
g
e
W
a
u
k
e
[
3
7
]
7
5
.
1
±
1
5
.
7
8
4
.
5
±
1
2
.
9
L
a
t
e
N
A
N
A
E
l
a
s
t
i
c
b
a
n
d
a
g
e
N
i
s
h
i
g
u
c
h
i
[
2
3
]
8
3
(
5
5
–
1
2
0
)
9
2
(
6
4
–
1
3
6
)
L
a
t
e
N
A
N
A
N
A
F
u
k
u
d
a
[
5
]
1
1
7
.
4
±
2
3
.
2
1
1
4
±
1
3
.
6
E
a
r
l
y
r
e
l
e
a
s
e
d
b
e
f
o
r
e
w
o
u
n
d
c
l
o
s
u
r
e
1
4
8
N
A
L
i
[
1
8
]
7
3
±
1
9
8
2
±
1
5
L
a
t
e
0
N
A
C
o
m
p
r
e
s
s
i
v
e
d
r
e
s
s
i
n
g
p
l
u
s
w
o
o
l
a
n
d
c
r
e
p
e
b
a
n
d
a
g
e
N
A
n
o
t
a
v
a
i
l
a
b
l
e
o
r
n
o
t
a
p
p
l
i
c
a
b
l
e
a
p
r
e
s
e
n
t
e
d
b
y
m
e
a
n
,
m
e
a
n
±
S
D
,
o
r
r
a
n
g
e
b
L
a
t
e
=
r
e
l
e
a
s
e
d
a
f
t
e
r
w
o
u
n
d
c
l
o
s
u
r
e
a
n
d
c
o
m
p
r
e
s
s
i
v
e
d
r
e
s
s
i
n
g
c
P
o
s
t
o
p
e
r
a
t
i
v
e
h
o
u
r
s
1124 Knee Surg Sports Traumatol Arthrosc (2011) 19:1121–1130
123patients. In the non-tourniquet group, various incidences of
embolism were reported during different steps of the
operation.
Three studies [1, 33, 36] reported wound problems,
including signiﬁcant hematoma, wound oozing, skin blis-
tering, bruising, superﬁcial wound infection requiring
antibiotics treatment, and skin necrosis. The tourniquet
group was found to have a higher incidence of postopera-
tive wound problems than the non-tourniquet group (risk
ratio: 3.04, P = 0.008, 95%CI: 1.33–6.95).
Eight studies reported a comparison of operation times
between the two groups [2, 5, 12, 18, 23, 33, 35, 37].
Subgroup analysis was done according to the timing of
releasing tourniquet. Using the tourniquet with early
release (deﬂation after cementing for hemostasis) did not
shorten the operation time. However, late release of tour-
niquet (deﬂation after wound closure and dressing) would
shorten the operation time compared with non-tourniquet
groups (Fig. 3). The overall pooling results also found
signiﬁcant shorter operation time in tourniquet group.
Fig. 1 a Total measured blood
loss: The pooling data of the
ﬁve studies favored using a
tourniquet. However, Harvey
et al. [7] had an extreme result.
The total measured blood loss in
the non-tourniquet group was
twice that in the tourniquet
group (1,493 versus 709 ml)
probably because of cementless
technique and prolonged
surgical time. After taking out
this result, the pooling data of
the remaining studies showed
no signiﬁcant difference.
b Calculated blood loss: The
pooling results revealed slightly
less calculated blood loss in the
non-tourniquet group.
c Intraoperative blood loss: All
of ﬁve studies showed that using
a tourniquet signiﬁcantly
decreased blood loss during the
operation. The mean
intraoperative blood loss in
operations without a tourniquet
ranged from 295 to 631 ml.
d Postoperative blood loss: The
pooling data revealed a slight
decrease in the drained volume
of the non-tourniquet group.
The means of the total drained
blood ranged from 290 to
528.5 ml in the tourniquet group
and 145 to 661.6 ml in the non-
tourniquet group. Overall,
pooling date showed that using
a tourniquet in TKA could
reduce the intraoperative blood
loss and total measured blood
loss, but could not decrease the
calculated blood loss
Knee Surg Sports Traumatol Arthrosc (2011) 19:1121–1130 1125
123Fig. 2 Results of the meta-
analysis of overall clinical
thromboembolic events
(a) showed the risk of overall
thromboembolic complications
was increased by using the
tourniquet, although there was
no signiﬁcant difference in the
subgroup analysis of clinical
pulmonary embolism (b) and
clinical deep vein thrombosis
(c). The two studies of
sonographic deep vein
thrombosis (d) showed different
results of incidence. Fukuda
et al. showed a high incidence in
both groups (77.8% (21/27) in
the tourniquet group and 85.7%
(18/21) in the non-tourniquet
group, respectively), whereas
the other study reported a low
incidence (1/37 in the tourniquet
group and 0/40 in the non-
tourniquet group, respectively)
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123Discussion
The most important ﬁnding of the present meta-analysis
was that the true blood loss in TKA was not reduced using
a tourniquet, although intraoperative blood loss was sig-
niﬁcantly less in tourniquet group. In addition, more
thromboembolic events and wound complications were
identiﬁed in the tourniquet group. The effectiveness and
safety proﬁle of the tourniquet are questionable.
The pooling data showed that the patients with whom a
tourniquet was used in TKA had less total measured
operative blood loss. However, we now know that the total
measured blood loss represents only a fraction of the true
blood loss. The new concept of ‘‘calculated blood loss’’
was introduced using Gross’ method [6]. Various studies
have indicated that this method likely provides a much
more accurate estimation of the true blood loss, than
measured blood loss [27, 30]. The pooling results in the
meta-analysis found no signiﬁcant difference between the
two groups. Two current studies even showed that using a
tourniquet caused more calculated blood loss [18, 33].
Therefore, we concluded that using a tourniquet does not
reduce the overall blood loss effectively.
The results of this analysis also conﬁrmed that there is
often a substantial hidden or unmeasured blood loss in
TKA [28]. The intraoperative and total measured blood
loss were signiﬁcantly less in the tourniquet group than in
the non-tourniquet group, but the pooling results of cal-
culated blood loss showed no signiﬁcant difference. This
phenomenon suggests that TKA involves some blood loss
that is not recognized in the routine assessment of either
intraoperative blood loss or the postoperative drainage
amount, especially when using a tourniquet during the
operation [18]. Surgeons tended to underestimate the sur-
gical blood loss in this situation. In fact, reactive blood
ﬂow increases with the peak ﬂow appearing within 5 min
Table 3 Risk ratio of thromboembolic events
Incidence Risk ratio (95% CI) Number needed to harm
(NNH) for using a tourniquet
Using a tourniquet No tourniquet
Clinical thromboembolic events 13.0% (27/208) 6.1% (12/196) 1.91 (1.05–3.49) 14.5
Symptomatic deep vein thrombosis 14.0% (19/135) 7.1% (9/126) 1.76 (0.87–3.56) 14.5
Symptomatic pulmonary embolism 9.8% (8/82) 3.4% (3/88) 2.54 (0.78–8.25) 15.6
Sonographic deep vein thrombosis 34.4% (22/64) 30.0% (18/61) 0.84 (0.23–3.09) 22.7
The risk ratios were calculated by using the ﬁxed effect Mantel–Haensezl method. Each study had a different weight
Clinical thromboembolic events included symptomatic deep vein thrombosis and symptomatic pulmonary embolism
Fig. 3 Results of meta-analysis
of operation time and the
following subgroup analysis.
Three studies with early release
of tourniquet showed no
difference between tourniquet
and non-tourniquet groups. Five
studies with late release of
tourniquet showed shorter
operation time in tourniquet
group
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123after the tourniquet is released [16]. This ﬁnding supports
the notion that patients with whom a tourniquet is used
might have more hidden blood loss after the operation.
Thromboembolism is one of the most common com-
plications after TKA and is of great concern because of the
associated increases in morbidity and mortality reported in
the literature. In the meta-analysis, we found the incidence
of clinical thromboembolic events was higher in patients
managed with a tourniquet than in those without it. The
critical point is the deﬂation of the tourniquet right after
the operation. Transesophageal echocardiography demon-
strated shower-like echogenic materials circulating from
the lower limbs to the right atrium, ventricle, and pul-
monary artery after release of the tourniquet [12, 37]. This
phenomenon lasted for several minutes. The histological
examination of these materials showed only thrombi, and
no fat, bone marrow, or bone cement [3]. Fortunately, the
sonographic phenomenon of embolism was not always
clinically relevant. Although the transesophageal echocar-
diography was thought to be over sensitive, these results
hinted us that the thromboembolism was an important issue
requiring careful management. To date, no approach to
venous thromboembolic prophylaxis has been universally
accepted by orthopedic surgeons. The methods of pro-
phylaxis varied among the included studies. Our results
suggested that this issue should be of great concern in TKA
performed with tourniquet inﬂation.
The circulatory stasis caused by tourniquet inﬂation
worsened the local soft tissue condition and might have
impaired wound healing. Fortunately, most of the compli-
cations were mild. Other confounding factors also inﬂu-
enced the soft tissue condition and wound healing. Further
studies are needed to investigate the effect of the tourniquet
on wound healing.
Regarding the operation time, we should take the timing
of tourniquet deﬂation into account. The tourniquet was
released after wound closure and compressive dressing in
ﬁve studies [12, 18, 23, 35, 37]. The pooling result of the
operation time among them showed signiﬁcantly shorter in
the tourniquet group. Three studies with early release of
tourniquet did not report this beneﬁt [2, 5, 33]. This ﬁnding
was consistent with our experience and the recent trials
[34]. Releasing the tourniquet right after cementing the
prosthesis for hemostasis would cause longer operation
time than releasing it after wound closure. However, the
inﬂuence of the timing of release on blood loss is still
controversial [25, 29].
The bias of these studies might come from the mea-
surement of intraoperative blood loss. Most of surgeon
counted intraoperative blood loss according to the amount
of blood in suction bags. This method might underestimate
the blood loss when the tourniquet was not used. Several
included articles mentioned how they accurately measured
the intraoperative blood loss [2, 7, 18, 33]. Most of them
counted the suction amount and weighed sponges or gauzes
in the operative room. The other perioperative management
may also impact on blood loss. Some examples are number
of drains, timing of removal of drains, temporary clamping
of drains or not, and type of postoperative compressive
dressing (Table 2). No author temporarily clamped the
drain after the operations in our included studies. We did
not found the methods of drainage and dressing as con-
founding factors in our results.
Weevaluatedthequalityofthe includedstudies using the
CONSORT statement, which included 22 items for the
analysis of randomized controlled trials. The lack of any of
theitemsisassociatedwithbiasedestimates ofthetreatment
effect, because the information is essential to judge the
reliability or relevance of the ﬁndings [22]. Our assessment
revealed that the weakness of the included randomized
studies was mainly the poor methods or description of ran-
domization. Two of the three prospective non-randomized
studies allocated the consecutive patients into tourniquet or
non-tourniquet groups based on the date of operation to
minimize the bias [5, 23]. The other study was part of a
double-blind thromboprophylaxis trial [7]; no clear state-
ment of criteria for patient selection was reported.
The major limitation of this analysis is the small sample
size. We could not perform statistical tests to eliminate the
publication bias. However, such bias was minimized by our
comprehensive search, duplicate selection process, and
evaluation of methodology. One article reported the oper-
ation time as mean and ranges rather than standard devia-
tions [35]. We treated the results as normally distributed
data, so the standard deviations were estimated to be one-
quarter of the ranges of the data values [9]. This estimation
might generate bias. However, excluding this study did not
change the conclusion of the pooled results.
Although some reports opposing the use of the tourni-
quet in TKA have been published, the issue remains con-
troversial and the technique is still widely used by surgeons
when performing TKA. We suggested that the tourniquet
should not be used in patients with high risks of throm-
boembolism. The thromboprophylaxis and closely moni-
toring the patients postoperatively are mandatory if the
tourniquet was using in TKA. In addition, the hidden blood
loss should be kept in mind due to the reactive blood ﬂow
after deﬂation of the tourniquet. The postoperative hemo-
globin and hematocrit levels should always be checked to
evaluate the blood loss and the need for blood transfusion.
Conclusion
This meta-analysis provided the best evidence regarding
the application of the tourniquet in TKA to date because
1128 Knee Surg Sports Traumatol Arthrosc (2011) 19:1121–1130
123the sample size was far more than those in each single
study. The available evidence indicated that although using
the tourniquet provided good visualization of the surgical
ﬁeld, it could not reduce the actual blood loss. It saved the
operation time only when it was released after wound
closure and dressing. The tourniquet might be associated
with an increased incidence of thromboembolic events and
wound complications. When using the tourniquet in TKA,
the surgeons should carefully consider its effectiveness and
safety. Inﬂating the tourniquet only while cementing or for
limited time might be an option. Additional well-designed
randomized controlled trials are required to clarify the roles
of tourniquet and compare the effects of different methods
of tourniquet applications in TKA.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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